Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000467507 | SCV000561568 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2024-10-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000612974 | SCV000725359 | likely benign | not specified | 2017-11-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000774920 | SCV000908963 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000774920 | SCV002609972 | likely benign | Hereditary cancer-predisposing syndrome | 2020-09-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |